https://www.marketscreener.com/quote/stock/VALNEVA-54466/news/Valneva-Reports-Successful-Outcome-of-Phase-2-Run-In-for-its-Lyme-Disease-Vaccine-Candidate-28746261/?utm_source=telegram&utm_medium=social&utm_campaign=share